# Hyperbaric Oxygen Brain Injury Treatment Trial

> **NCT02407028** · PHASE2 · RECRUITING · sponsor: **Gaylan Rockswold** · enrollment: 200 (estimated)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** Hyperbaric oxygen (1.5 ATA, no NBH)
- **DRUG:** Hyperbaric oxygen (2.0 ATA, no NBH)
- **DRUG:** Hyperbaric oxygen (2.5 ATA, no NBH)
- **DRUG:** Hyperbaric oxygen (1.5 ATA + NBH)
- **DRUG:** Hyperbaric oxygen (2.0 ATA + NBH)
- **DRUG:** Hyperbaric oxygen (2.5 ATA + NBH)
- **DRUG:** Normobaric Hyperoxia (NBH)
- **OTHER:** Usual Care

## Key facts

- **NCT ID:** NCT02407028
- **Lead sponsor:** Gaylan Rockswold
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-06-25
- **Primary completion:** 2028-10-26
- **Final completion:** 2029-06-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-10-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02407028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02407028, "Hyperbaric Oxygen Brain Injury Treatment Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02407028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*